Arcutis Biotherapeutics, Inc. (ARQT)
29.10
+2.69
(+10.19%)
USD |
NASDAQ |
Oct 15, 16:00
29.10
0.00 (0.00%)
After-Hours: 20:00
Arcutis Biotherapeutics Cash from Operations (TTM) : 39.31M for June 30, 2026
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 39.31M |
| March 31, 2026 | 26.99M |
| December 31, 2025 | -5.625M |
| September 30, 2025 | -32.56M |
| June 30, 2025 | -65.49M |
| March 31, 2025 | -110.94M |
| December 31, 2024 | -112.16M |
| September 30, 2024 | -167.65M |
| June 30, 2024 | -176.95M |
| March 31, 2024 | -198.32M |
| December 31, 2023 | -247.06M |
| September 30, 2023 | -261.88M |
| June 30, 2023 | -285.59M |
| March 31, 2023 | -281.08M |
| Date | Value |
|---|---|
| December 31, 2022 | -257.72M |
| September 30, 2022 | -238.36M |
| June 30, 2022 | -211.55M |
| March 31, 2022 | -185.40M |
| December 31, 2021 | -174.63M |
| September 30, 2021 | -155.02M |
| June 30, 2021 | -148.30M |
| March 31, 2021 | -138.23M |
| December 31, 2020 | -113.03M |
| September 30, 2020 | -99.02M |
| June 30, 2020 | -75.78M |
| March 31, 2020 | -58.17M |
| December 31, 2019 | -44.24M |
| September 30, 2019 | -31.98M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 160.32M |
| Insmed, Inc. | -778.92M |
| Emergent BioSolutions, Inc. | 97.70M |
| Exelixis, Inc. | 1.183B |
| Puma Biotechnology, Inc. | 41.15M |